undamentalytics Newsletter
Sign in

Arteris, Inc. (AIP) stock

Add to watchlist

Add holding +

NASDAQ: AIP Nasdaq Semiconductors Next results ~November 5, 2026

C Fundamentals grade

Arteris, Inc. is a US-listed company in the semiconductors industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$6.5

Valuation models combined (2)

Base case. Range ~$5.4–$7.0. Weighted average of 2 models (forward price-to-sales vs peers, revenue-to-maturity model).

Price vs value

No Buy/Hold/Sell rating is issued: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Arteris, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 9 selling0 purchases and 221 sales by directors and officers, last 12 monthsInsider trades
  • Funds161 adding, 59 cuttingOf 40 active managers that changed their stake, 29 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Arteris files

Where Arteris stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $85m, up 33.8% on a year earlier, faster than the 25.6% growth a quarter earlier. That growth ranks 10 of 53 among the semiconductor companies we cover. Free-cash-flow margin rose to 8.0% from -2.8% a year earlier. The diluted share count is up 10.6% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades C. It passes 2 of our 3 financial-health checks. Our revenue-to-maturity cash-flow model value is $7.40 a share, against a share price of $20.83.

Source: 10-Q filed August 6, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 5, 2026 (estimated)

Arteris, Inc.'s trailing-twelve-month revenue grew 33.8% year on year, with a free-cash-flow margin of 8.0%. Where it stands out: gross margin of 87.6% ranks 2 of 73 semiconductor companies we cover. Where it lags: stock pay as % of revenue of 25.3% ranks 65 of 74 semiconductor companies we cover.

Current signal Revenue growth accelerating: TTM revenue growth rose to 33.8% (+8.2pp vs the prior quarter).

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 33.8% over the last 12 months, against a median of 13.7% for semiconductor companies we cover.
  • Growth speeding up. The growth rate is 8.2 points higher than a quarter earlier.
  • Net cash. Cash exceeds long-term debt by $0.1bn.

Things to watch

  • Results due soon. Results are expected around 3 November; the share price can move sharply on the day.
  • Loss-making. Operating margin is -47.7%: costs exceed revenue.
  • Heavy stock-based pay. Stock pay equals 25.3% of revenue, against a median of 6.4% for semiconductor companies we cover: a real cost that cash-flow figures leave out.
  • Share dilution. Diluted shares rose 10.6% in a year.
  • Volatile shares. Over the past year the shares showed annualised volatility of 79% and a beta of 3.7 against the S&P 500.
  • Insiders selling. 9 insiders sold $120M of stock over the past 365 days and none bought (90% under pre-set trading plans).

Latest results: FY2026 Q2

Filed August 6, 2026
Earnings per share
-$0.10 against an average estimate of -$0.04: missed by 140.0%
Revenue
$24m, up 46.2% on a year earlier
Share reaction
-3.7% in the first session after the results on August 6, 2026, against +0.5% for the S&P 500
Guidance given
ACV + royalties $99m to $103m (Q3 2026); ACV + royalties $102m to $106m (FY 2026)
Next report
November 5, 2026; average EPS estimate -$0.04

Arteris' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-5.1%
  • 1 week-8.2%
  • 1 month-27.6%
  • This year+15.2%
  • 1 year+31.2%
  • 5 years-20.2%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$84.6M
Operating margin
-47.7%
Net margin
-46.7%
EPS (TTM, diluted)
$-0.88

Growth

Revenue growth
+33.8%
Change in growth rate
+8.2 pts
Share count change
+10.6%

Cash

Free cash flow (TTM)
$6.8M
FCF margin
8.0%
Stock pay % of revenue
25.3%

Earnings

Last results
August 6, 2026
Next results (est.)
November 3, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Insider trade
  2. Insider trade
  3. Results
  4. Leadership
  5. Guidance

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Arteris, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Valuation models

We value Arteris, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 13.3%: the 10-year Treasury yield (4.9%) plus a beta of 1.86 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$1.8 ~$1.3–$2.2 Left out: out of range vs price (0.10x)
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$1.9 ~$1.8–$3.2 Left out: out of range vs price (0.11x)
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: the model gives no positive value
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$5.4 ~$5.2–$15 Included, half weight
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. ~$7.0 ~$6.0–$8.3 Included
Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$6.5 ~$5.4–$7.0 2 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Arteris, Inc. with Semiconductors in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20212022202320242025Now
Share price$21.11$4.30$5.89$10.19$15.50$17.85
Market value$464m$140m$210m$397m$656m$800m
+ Net debt (− = net cash)−$86m−$37m−$14m−$14m−$34m−$93m
Enterprise value$378m$103m$196m$383m$622m$707m
Multiples
Price / sales 12.2x2.8x3.9x6.9x9.3x9.5x
Price / earnings ——————
Price / free cash flow ————122.6x118.3x
EV / EBITDA ——————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

65 /100

Moderate moat

How hard Arteris's competitive advantage looks for rivals to wear away, judged from 6 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 20 / 20

    Cash operating profit has been a median 20.2% of total assets over 5 years.

  • Pricing power 20 / 20

    Gross margin has been a median 90.5%, moving by 1.9 percentage points (standard deviation) across 6 years.

  • Durability 10 / 20

    Operating margin has been a median -49.9%; its worst year was -66.3%.

  • Cash conversion 2 / 20

    Free cash flow was positive in 1 of 5 years, at a median -2.8% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 5, 2026, after the close. Analysts expect revenue of $25m and EPS of −$0.04 (range −$0.07 to −$0.02) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$0.18 +47% $97m +37%
Next $0.12 +171% $117m +21%

Next year's EPS estimate has moved −21.1% in 90 days, across 7 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +72.3% on 90 days ago. In the last 30 days, 0 analysts raised Arteris, Inc.'s forecast and 4 cut it.

Consensus EPS forecast Arteris, Inc., last 90 days
−$0.20 −$0.10 $0.00 $0.10 $0.20 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$0.10 Current fiscal year, 60 days ago: −$0.17 Current fiscal year, 30 days ago: −$0.17 Current fiscal year, 7 days ago: −$0.18 Current fiscal year, Now: −$0.18 −$0.18 Next fiscal year, 90 days ago: $0.16 Next fiscal year, 60 days ago: $0.12 Next fiscal year, 30 days ago: $0.12 Next fiscal year, 7 days ago: $0.12 Next fiscal year, Now: $0.12 $0.12

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$0.10$0.16
60 days ago −$0.17$0.12
30 days ago −$0.17$0.12
7 days ago −$0.18$0.12
Now −$0.18$0.12

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 −$0.04 −$0.10 −140.0%
Dec 2025 −$0.07 −$0.05 +25.9%
Sept 2025 −$0.09 −$0.09 +2.7%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 6, 2026
  • Revenue FY 2026 $95m to $98m
    “Revenue $24.0 - $25.0 $95.0 - $98.0” source
  • Revenue Q3 2026 $24m to $25m New
    “Revenue $24.0 - $25.0 $95.0 - $98.0” source
  • ACV + royalties FY 2026 $102m to $106m
    “ACV + royalties $99.0 - $103.0 $102.0 - $106.0” source
  • Non-GAAP operating loss FY 2026 $7m to $10m Non-GAAP
    “Non-GAAP operating loss $1.0 - $3.0 $7.0 - $10.0” source
  • Free cash flow FY 2026 $5m to $9m
    “Free cash flow * $5.0 - $9.0” source
  • ACV + royalties Q3 2026 $99m to $103m New
    “ACV + royalties $99.0 - $103.0 $102.0 - $106.0” source
Show 1 more item
  • Non-GAAP operating loss Q3 2026 $1m to $3m Non-GAAP New
    “Non-GAAP operating loss $1.0 - $3.0 $7.0 - $10.0” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Analyst recommendations

7 analysts, Oct 2026
Buy7100%
Hold00%
Sell00%

Monthly trend

  1. Oct 202677
  2. Sep 202677
  3. Aug 202666
  4. Jul 2026415

Counts of recommendations published by analysts covering Arteris, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
7.2%
of tradable shares
Days to cover
4.05
at average volume
Short interest, 1 month
+8%
to October 15, 2026
Held by institutions
66%
of shares
Held by insiders
19.9%
of shares
Employees
364
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +31.2%

$13.61 on October 31, 2025 to $17.85

ThenNowEffect
Revenue (last 12 months) $63m $85m +33.8%
P/S multiple 8.7x 9.5x +8.4%
Share count 41m 45m −9.6%

Biggest factor: revenue. Loss-making at one end, so the split uses price/sales.

Last 3 years +168.0%

$6.66 on November 3, 2023 to $17.85

ThenNowEffect
Revenue (last 12 months) $52m $85m +63.7%
P/S multiple 4.4x 9.5x +115.4%
Share count 34m 45m −24.0%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 20222023202420252026 to date
Return
AIP−80%+37%+73%+52%+15%
Industry peers (median)−34%+15%−15%+16%+15%
S&P 500−18%+26%+25%+18%+11%
Months that ended higher
AIP17%50%67%67%46%
S&P 50042%67%75%75%46%
Largest fall from a high during the year
AIP−84%−45%−29%−55%−63%
S&P 500−25%−10%−8%−19%−9%

Worst fall since October 27, 2021: 88% from November 30, 2021 to December 14, 2022. Getting back needed a 708% gain, reached on April 30, 2026, 1233 days after the low.

Price behaviour

52-week range
$12.32 – $48.59
From 52-week high
−63.3%
vs 50-day average
−18.2%
vs 200-day average
−28.7%
Volatility (1 year)
79%
Beta vs S&P 500
3.68

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
7 up, 5 down
typical move ±11.3%
After a week
6 up, 6 down
typical move ±12.5%
After a month
8 up, 4 down
typical move ±20.7%
Results releasedNext dayS&P 500 next day5 days21 days
August 6, 2026 −3.7% +0.5% −10.8% −30.9%
May 12, 2026 +7.3% +0.4% +3.8% +12.6%
February 12, 2026 −3.2% −1.5% −2.5% +0.7%
November 4, 2025 +18.6% −0.8% +18.5% +27.8%
August 5, 2025 +4.6% +0.3% +5.4% −6.5%
May 13, 2025 −4.6% +0.8% −6.4% +7.6%
February 18, 2025 +2.4% +0.5% −8.9% −18.9%
November 5, 2024 +25.6% +3.7% +22.9% +31.0%
August 1, 2024 −8.7% −3.3% −13.4% +4.8%
May 2, 2024 +31.4% +2.2% +34.7% +24.2%
February 20, 2024 −7.5% −0.5% −11.3% −6.9%
May 4, 2023 +17.5% +1.1% +11.5% +75.9%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Arteris, Inc. in five measures

Fundamentals grade C
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Arteris, Inc.
$50M $60M $70M $80M $90M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $52.4M Revenue (TTM), FY23 Q4: $53.7M Revenue (TTM), FY24 Q1: $53.5M Revenue (TTM), FY24 Q2: $53.3M Revenue (TTM), FY24 Q3: $54.7M Revenue (TTM), FY24 Q4: $57.7M Revenue (TTM), FY25 Q1: $61.3M Revenue (TTM), FY25 Q2: $63.2M Revenue (TTM), FY25 Q3: $65.9M Revenue (TTM), FY25 Q4: $70.6M Revenue (TTM), FY26 Q1: $77M Revenue (TTM), FY26 Q2: $84.6M $84.6M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $52.4M
FY23 Q4 $53.7M
FY24 Q1 $53.5M
FY24 Q2 $53.3M
FY24 Q3 $54.7M
FY24 Q4 $57.7M
FY25 Q1 $61.3M
FY25 Q2 $63.2M
FY25 Q3 $65.9M
FY25 Q4 $70.6M
FY26 Q1 $77M
FY26 Q2 $84.6M
Revenue growth, TTM YoY Arteris, Inc.
0% 10% 20% 30% 40% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 3.5% Revenue growth, TTM YoY, FY23 Q4: 6.5% Revenue growth, TTM YoY, FY24 Q1: 3.2% Revenue growth, TTM YoY, FY24 Q2: 3.1% Revenue growth, TTM YoY, FY24 Q3: 4.5% Revenue growth, TTM YoY, FY24 Q4: 7.6% Revenue growth, TTM YoY, FY25 Q1: 14.7% Revenue growth, TTM YoY, FY25 Q2: 18.6% Revenue growth, TTM YoY, FY25 Q3: 20.4% Revenue growth, TTM YoY, FY25 Q4: 22.3% Revenue growth, TTM YoY, FY26 Q1: 25.6% Revenue growth, TTM YoY, FY26 Q2: 33.8% 33.8%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 3.5%
FY23 Q4 6.5%
FY24 Q1 3.2%
FY24 Q2 3.1%
FY24 Q3 4.5%
FY24 Q4 7.6%
FY25 Q1 14.7%
FY25 Q2 18.6%
FY25 Q3 20.4%
FY25 Q4 22.3%
FY26 Q1 25.6%
FY26 Q2 33.8%
Operating margin (TTM) Arteris, Inc.
-80% -60% -40% -20% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: -66.7% Operating margin (TTM), FY23 Q4: -65.5% Operating margin (TTM), FY24 Q1: -66.4% Operating margin (TTM), FY24 Q2: -64.3% Operating margin (TTM), FY24 Q3: -61.6% Operating margin (TTM), FY24 Q4: -54.7% Operating margin (TTM), FY25 Q1: -49.2% Operating margin (TTM), FY25 Q2: -49.0% Operating margin (TTM), FY25 Q3: -48.2% Operating margin (TTM), FY25 Q4: -47.0% Operating margin (TTM), FY26 Q1: -45.1% Operating margin (TTM), FY26 Q2: -47.7% -47.7%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 -66.7%
FY23 Q4 -65.5%
FY24 Q1 -66.4%
FY24 Q2 -64.3%
FY24 Q3 -61.6%
FY24 Q4 -54.7%
FY25 Q1 -49.2%
FY25 Q2 -49.0%
FY25 Q3 -48.2%
FY25 Q4 -47.0%
FY26 Q1 -45.1%
FY26 Q2 -47.7%
FCF margin (TTM) Arteris, Inc.
-40% -20% 0% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: -27.9% FCF margin (TTM), FY23 Q4: -32.1% FCF margin (TTM), FY24 Q1: -15.8% FCF margin (TTM), FY24 Q2: -11.3% FCF margin (TTM), FY24 Q3: -3.2% FCF margin (TTM), FY24 Q4: -1.8% FCF margin (TTM), FY25 Q1: 2.2% FCF margin (TTM), FY25 Q2: -2.8% FCF margin (TTM), FY25 Q3: -0.6% FCF margin (TTM), FY25 Q4: 7.6% FCF margin (TTM), FY26 Q1: -6.1% FCF margin (TTM), FY26 Q2: 8.0% 8.0%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 -27.9%
FY23 Q4 -32.1%
FY24 Q1 -15.8%
FY24 Q2 -11.3%
FY24 Q3 -3.2%
FY24 Q4 -1.8%
FY25 Q1 2.2%
FY25 Q2 -2.8%
FY25 Q3 -0.6%
FY25 Q4 7.6%
FY26 Q1 -6.1%
FY26 Q2 8.0%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 32 38 50 54 58 71 85
Gross profit 30 34 46 49 52 64 74
EBITDA −3 −20 −27 −32 −28 −30 −36
Operating income −4 −22 −29 −35 −32 −33 −40
Net income −3 −23 −27 −37 −34 −35 −40
Diluted EPS −$0.19 −$1.06 −$0.84 −$1.03 −$0.86 −$0.82 −$0.88
Growth (year on year)
Revenue — +19.0% +33.0% +6.5% +7.6% +22.3% +33.8%
Margins
Gross margin 95.3% 90.1% 91.5% 90.5% 89.7% 90.2% 87.6%
EBITDA margin −8.9% −53.5% −53.1% −59.8% −48.9% −42.2% −42.4%
Operating margin −11.9% −57.5% −57.3% −65.5% −54.7% −47.0% −47.7%
Net margin −10.2% −61.8% −54.4% −68.7% −58.3% −49.2% −46.7%
Free-cash-flow margin 4.7% −4.3% −15.5% −32.1% −1.8% 7.6% 8.0%
Cash flow
Cash from operations 2 −1 −7 −16 −1 7 9
Capital spending 1 1 1 2 0 1 2
Free cash flow 2 −2 −8 −17 −1 5 7
Stock-based pay 0 6 12 15 16 18 21
Free cash flow after stock pay 1 −7 −20 −32 −17 −13 −15
Balance sheet
Cash 12 86 37 14 14 34 93
Total debt 0 0 0 0 0 0 0
Net debt (negative = net cash) −12 −86 −37 −14 −14 −34 −93
Diluted shares 18m 22m 33m 36m 39m 42m 45m

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 3 checks passed · June 30, 2026
What it owns · $225m
Short-term assets $146mLonger-term assets $78m
What it owes, and who funded it · $225m
Short-term liabilities $93mLonger-term liabilities $64mShareholders' equity $68m
  • Short-term assets cover short-term liabilities $146m of assets due within a year against $93m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $146m short-term assets against $64m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of −$40m against $171,000 of interest.

From Arteris, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
+10.6%
year over year
R&D spending
67.5%
of revenue
Days sales outstanding
66 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in semiconductors
Last 12 months unless stated AIP VLN MRAM CEVA NVTS INDI Median
Revenue, last 12 months $85m $71m $62m $116m $37m $231m $1.1bn
Revenue growth, last 12 months 33.8% 22.1% 20.9% 8.8% −46.4% 6.2% 13.7%
Revenue growth, 3-year average 17.9% — 0.5% 1.8% −12.2% 14.1% 3.9%
Revenue growth, latest quarter 46.2% — 41.9% 13.1% −27.3% 24.0% 20.1%
Gross margin 87.6% 62.4% 52.3% 87.5% 38.1% 37.8% 48.3%
Operating margin −47.7% −48.2% −15.5% −8.3% −316.9% −63.3% 4.8%
Operating margin, 3-year average −53.7% — −10.0% −9.9% −204.8% −66.9% 4.8%
Net margin −46.7% −44.7% −4.2% −9.5% −856.9% −64.8% 5.3%
Cash from operations / revenue 10.1% −18.0% 6.8% 3.3% −181.9% −30.9% 17.4%
Free-cash-flow margin 8.0% −19.5% −8.6% −0.9% −185.7% −36.2% 9.6%
Free-cash-flow margin, 3-year average −2.0% — 5.1% −1.9% −111.3% −35.0% 8.5%
Stock pay / revenue 25.3% 23.4% 8.7% 18.2% 74.3% 30.3% 5.8%
Change in share count 10.6% −2.2% 2.3% 10.8% 20.2% 9.2% 0.9%

Median of all 75 companies we cover in semiconductors. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

75 semiconductor companies
Measure Company Peer median Rank
Revenue growth Growth 33.8% 13.7% 15 of 75
Change in growth rate Growth +8.2pp +3.7pp 21 of 75
Gross margin Profitability 87.6% 48.3% 2 of 73
Operating margin Profitability -47.7% 4.8% 61 of 75
Net margin Profitability -46.7% 5.3% 61 of 75
Free-cash-flow margin Cash generation 8.0% 9.6% 41 of 75
Stock pay as % of revenue Cash generation 25.3% 6.4% 65 of 74
Change in share count Balance sheet 10.6% 0.9% 60 of 72
Days sales outstanding Balance sheet 66 days 58 days 42 of 62

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
License and Maintenance $63.9M 90.5% ▲ 20.9%
Variable Royalties and Other $6.7M 9.5% ▲ 36.9%
Royalty $6.6M 98.2% ▲ 49.7%
Other services $124,000 1.8% ▼ 75.4%
Geography
Region Revenue Share YoY
Asia Pacific $33.6M 47.5% ▲ 20.8%
China $17.3M 51.4% ▲ 2.3%
South Korea $8.6M 25.5% ▲ 52.3%
Europe and Middle East $7.7M 22.8% ▲ 6.3%
Americas $29.3M 41.5% ▲ 29.1%
United States $28M 95.6% ▲ 28.8%
Other Americas $1.3M 4.4% ▲ 36.4%
Other Asia $7.8M 11.0% ▲ 46.2%

From Arteris, Inc.'s 10-K filed February 12, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$1.6B
Institutions reporting
210
Shares held vs prior quarter
▲ 15.1%
Positions opened / closed
78 / 18

Top buyers and sellers, Q2 2026: 161 institutions bought and 59 sold ; the biggest buyer was Blackrock, Inc (+1.2M shares) and the biggest seller Samjo Management, LLC (−804K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Needham Investment Management LLC $191M 3.9M 12.3% ▼ 0.6%
Blackrock, Inc. $160M 3.3M 10.3% ▲ 56.9%
Vanguard Capital Management LLC $73.6M 1.5M 4.7% ▲ 10.8%
Franklin Resources Inc $72.8M 1.5M 4.7% ▼ 15.2%
Federated Hermes, Inc. $68.6M 1.4M 4.4% ▲ 122.1%
Acadian Asset Management LLC $60.8M 1.3M 3.9% ▲ 34.2%
Nuveen, LLC $51.8M 1.1M 3.3% ▲ 37.6%
Goldman Sachs Group Inc $49M 1.0M 3.2% ▲ 6.4%
Jacobs Levy Equity Management, Inc $47.7M 982K 3.1% ▲ 61.6%
Geode Capital Management, LLC $43M 886K 2.8% ▲ 11.9%
State Street Corp $42.1M 867K 2.7% ▲ 6.2%
AQR Capital Management LLC $39.8M 819K 2.6% ▲ 19.4%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Arteris, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $120M 221 trades by 9 insiders · 90% under pre-set plans
Net ▼ $120M net selling
Insider Date Trade Shares Price Value
Moll Laurent R Chief Operating Officer October 5, 2026 Sell pre-set plan 12,219 $24.29 $296,775
Janac K Charles President and CEO October 5, 2026 Sell pre-set plan 11,452 $24.27 $277,987
Alpern Paul L VP and General Counsel October 5, 2026 Sell pre-set plan 6,003 $24.24 $145,500
Alpern Paul L VP and General Counsel October 2, 2026 Sell pre-set plan 1,010 $24.64 $24,890
Alpern Paul L VP and General Counsel October 2, 2026 Sell pre-set plan 1,181 $24.64 $29,104
Alpern Paul L VP and General Counsel October 2, 2026 Sell pre-set plan 765 $24.64 $18,852
Alpern Paul L VP and General Counsel October 2, 2026 Sell pre-set plan 692 $24.64 $17,053
Janac K Charles President and CEO October 2, 2026 Sell pre-set plan 1,966 $24.64 $48,448
Janac K Charles President and CEO October 2, 2026 Sell pre-set plan 1,843 $24.64 $45,417
Janac K Charles President and CEO October 2, 2026 Sell pre-set plan 2,775 $24.64 $68,385
Moll Laurent R Chief Operating Officer October 2, 2026 Sell pre-set plan 893 $24.64 $22,006
Moll Laurent R Chief Operating Officer October 2, 2026 Sell pre-set plan 1,889 $24.64 $46,551

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around November 3, 2026 estimated from the company's past filing pattern, not announced

  • August 6, 2026
  • May 12, 2026
  • February 12, 2026
  • November 4, 2025
  • August 5, 2025
  • May 13, 2025

Recent SEC filings

Data status

When each part of this page on Arteris, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Arteris, Inc. in brief

What does Arteris, Inc. do?
Arteris, Inc. is a US-listed company in the semiconductors industry. Its financial year ends in December.
What is Arteris, Inc.'s stock ticker?
Arteris, Inc. trades under the ticker AIP on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Arteris, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Arteris, Inc. reported revenue of $84.6M, 33.8% higher than a year earlier, according to its SEC filings.
What is Arteris, Inc.'s free cash flow?
Arteris, Inc.'s free-cash-flow margin is 8.0% of revenue over the trailing twelve months, ranking 41 of the 75 semiconductor companies we cover.
Who are Arteris, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Needham Investment Management LLC, Blackrock, Inc. and Vanguard Capital Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Arteris, Inc.'s market cap?
On November 2, 2026, Arteris, Inc.'s market capitalisation was about $800M and net debt of -$93.3M. Market figures come from third-party market data and may be delayed.
Who are Arteris, Inc.'s competitors?
In our Semiconductors peer group, the companies closest to Arteris, Inc. are Valens Semiconductor Ltd., Everspin Technologies Inc., Ceva Inc, Navitas Semiconductor Corp and Indie Semiconductor, Inc. The side-by-side comparison below sets their revenue, margins and growth against Arteris, Inc.'s.
Are insiders buying or selling Arteris, Inc. stock?
Over the last 12 months, Arteris, Inc.'s directors and officers reported 0 open-market purchases and 221 sales on Form 4. The insider trading page charts every trade.
When is Arteris, Inc.'s next earnings date?
Around November 5, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Arteris, Inc. announces its own schedule.